Hussman Strategic Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Hussman Strategic Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-20,000	Closed	-$1.17M	–	316
2020 Q2	$1.17M	Hold	20,000	–	–	0.3%	130
2020 Q1	$788K	Buy	+20,000	New	+$1.17M	0.21%	181
2016 Q3	–	Sell	-150,000	Closed	-$5.72M	–	217
2016 Q2	$5.72M	Hold	150,000	–	–	0.87%	50
2016 Q1	$6.18M	Buy	+150,000	New	+$6.18M	0.82%	50

Other funds holding SYNH

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Hussman Strategic Advisors's SYNH Position: Q3 2020 in Review

Hussman Strategic Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2020, closing a stake of 20,000 shares — an estimated $1.17M sold.

Hussman Strategic Advisors first reported a position in SYNH in Q1 2016 and held it in 4 quarters. The position peaked at $6.18M in Q1 2016. 300 funds tracked by Wall St. Rank hold SYNH as of Q3 2020.

Hussman Strategic Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2020 after selling out during the quarter.
Hussman Strategic Advisors sold 20,000 Syneos Health, Inc. Class A Common Stock shares in Q3 2020, an estimated $1.17M.
Hussman Strategic Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2016 and held it in 4 quarters.
Hussman Strategic Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $6.18M in Q1 2016.
300 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2020.

Based on Hussman Strategic Advisors's 13F filing for Q3 2020, filed 2 Nov 2020.